Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lotta Kangasniemi
Ad3-hTERT-E1a, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Related publications
112. A Novel Oncolytic Adenovirus Based on Human Adenovirus Serotype 17
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
A Fully Replication-Competent Adenovirus Vector With Enhanced Oncolytic Properties
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
The hTERT Promoter Enhances the Antitumor Activity of an Oncolytic Adenovirus Under a Hypoxic Microenvironment
PLoS ONE
Multidisciplinary
Therapeutic Efficacy of an hTERT Promoter-Driven Oncolytic Adenovirus That Expresses Apoptin in Gastric Carcinoma
International Journal of Molecular Medicine
Medicine
Genetics
Human Adenovirus Serotype 3 Vector Packaged by a Rare Serotype 14 Hexon
PLoS ONE
Multidisciplinary
646. Viral Spread of Adenovirus Serotype 5 Versus Serotype 3 in Epithelial Tumors
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Cancer Therapy With a Replicating Oncolytic Adenovirus Targeting the Hypoxic Microenvironment of Tumors
Clinical Cancer Research
Cancer Research
Oncology
Tamoxifen-Regulated Adenoviral E1A Chimeras for the Control of Tumor Selective Oncolytic Adenovirus Replication in Vitro and in Vivo
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
842. Increased Oncolytic Ability of a Double RGD-Modified Adenovirus in Ovarian Cancer
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
